|
| 38064128 | Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases - data from a tertiary care center. | Clin Exp Metastasis | 2024 |
| 36782325 | Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial. | Infect Agent Cancer | 2023 |
| 36181606 | Emerging systemic treatment options in meningioma. | J Neurooncol | 2023 |
| 37944590 | Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. | Nat Med | 2023 |
| 37750955 | Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma. | J Cancer Res Clin Oncol | 2023 |
| 37659290 | Young oncologists' perspective on the role and future of the clinician-scientist in oncology. | ESMO Open | 2023 |
| 37977000 | Prognosticators of survival in patients with metastatic pancreatic cancer and ascites. | | 2023 |
| 37219741 | Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer. | Clin Exp Metastasis | 2023 |
| 36842299 | Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey. | | 2023 |
| 37152051 | Editorial: Precision medicine approaches in radiotherapy and systemic therapy of brain metastases. | | 2023 |
| 36652557 | Active Remodeling of Capillary Endothelium via Cancer Cell-Derived MMP9 Promotes Metastatic Brain Colonization. | | 2023 |
| 37085569 | Understanding the activity of antibody-drug conjugates in primary and secondary brain tumours. | Nat Rev Clin Oncol | 2023 |
| 36947280 | Brain metastases from hepatopancreatobiliary malignancies. | Clin Exp Metastasis | 2023 |
| 36473447 | Career and Professional Development for Young Oncologists. | Oncol Res Treat | 2023 |
| 36993741 | Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. | Res Sq | 2023 |
| 36989885 | Clinical risk factors for ascites in metastatic pancreatic cancer. | ESMO Open | 2023 |
| 36731326 | Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy. | ESMO Open | 2023 |
| 37543970 | Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis. | J Neurooncol | 2023 |
| 37036472 | Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer. | Clin Cancer Res | 2023 |
| 34998049 | Changing characteristics, treatment approaches and survival of patients with brain metastasis: data from six thousand and thirty-one individuals over an observation period of 30 years. | Eur J Cancer | 2022 |
| 35510032 | Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle. | Ther Adv Med Oncol | 2022 |
| 35759854 | Development of an alarm symptom-based risk prediction score for localized oesophagogastric adenocarcinoma (VIOLA score). | ESMO Open | 2022 |
| 35941372 | Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial. | Nat Med | 2022 |
| 35429443 | Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron. | Cancer Cell | 2022 |
| 35998208 | Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns. | Clin Cancer Res | 2022 |
| 35798470 | Introducing pro and con discussions in ESMO Open-Cancer Horizons. | ESMO Open | 2022 |
| 35356207 | DNA Methylation Associates With Clinical Courses of Atypical Meningiomas: A Matched Case-Control Study. | Front Oncol | 2022 |
| 35665365 | Heme Biosynthesis Factors and 5-ALA Induced Fluorescence: Analysis of mRNA and Protein Expression in Fluorescing and Non-fluorescing Gliomas. | Front Med (Lausanne) | 2022 |
| 36115057 | CD34 microvascularity in low-grade glioma: correlation with 5-aminolevulinic acid fluorescence and patient prognosis in a multicenter study at three specialized centers. | J Neurosurg | 2022 |
| 34342680 | Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature. | J Neurol | 2022 |
| 35338086 | DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma. | J Immunother Cancer | 2022 |
| 35259675 | Active immunization with a Her-2/neu-targeting Multi-peptide B cell vaccine prevents lung metastases formation from Her-2/neu breast cancer in a mouse model. | Translational Oncology | 2022 |
| 35248840 | Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort study. | Eur J Cancer | 2022 |
| 35213082 | Prognostic impact of genetic alterations and methylation classes in meningioma. | Brain Pathol | 2022 |
| 35171337 | SARS-CoV-2-related mortality and treatment delays for cancer patients in Austria : Findings of a multicentric nationwide study. | Wien Klin Wochenschr | 2022 |
| 35162973 | Promotes the Proliferation and Invasive Properties of Human Head and Neck Squamous Cell Carcinoma Cells. | International Journal of Molecular Sciences | 2022 |
| 35158978 | New Approaches with Precision Medicine in Adult Brain Tumors. | Cancers (Basel) | 2022 |
| 35145254 | Correction: Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases. | Br J Cancer | 2022 |
| 34591965 | Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations. | JAMA Oncol | 2022 |
| 34410467 | SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic : Conclusions for crisis response at a high-volume oncology center. | Wien Klin Wochenschr | 2021 |
| 34297825 | Erratum to: Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors. | Neuro Oncol | 2021 |
| 33546427 | Prognostic Value of 5-ALA Fluorescence, Tumor Cell Infiltration and Angiogenesis in the Peritumoral Brain Tissue of Brain Metastases. | Cancers (Basel) | 2021 |
| 33540564 | Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System Lymphoma. | Cancers (Basel) | 2021 |
| 34121071 | Androgen Receptor is Expressed in Breast Cancer Brain Metastases. | Appl Immunohistochem Mol Morphol | 2021 |
| 33588158 | Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases. | ESMO Open | 2021 |
| 34064222 | 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers. | Cancers (Basel) | 2021 |
| 33956203 | Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma. | Cancer Immunol Immunother | 2021 |
| 33473170 | Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases. | Br J Cancer | 2021 |
| 33575085 | Degradation of BRD4 - a promising treatment approach not only for hematologic but also for solid cancer. | Am J Cancer Res | 2021 |
| 33995593 | Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab. | Ther Adv Med Oncol | 2021 |